| Name | Title | Contact Details |
|---|---|---|
Brad Turasky |
Vice President of Technology | Profile |
Motif FoodWorks is a food-technology company working to make plant-based foods better tasting, more nutritious and so desirable that people actually crave them. Our mission is to unleash the promise of plant-based foods by taking a new, holistic approach to ingredient development that combines science and technology — merged with sensory fundamentals — to reveal totally new answers. By radically changing our understanding of plant-based food, Motif will enable crave-worthy products that exceed taste and experience expectations, unlocking benefits for everyone and our planet.
The Raleys Companies, grocery giants, were founded 90 years ago and proudly serve 7 states and 4 tribal nations with quality food, service, and innovation.
We’re committed to making the world a healthier place with solutions for the nutrition, food, sterilization, and energy markets.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.
Family Owned & Operated Flavor and Blending Company Specializing in Savory Flavors, Spices & Blends as well as Compounding Materials.